Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients

Rev Invest Clin. 2022 Jan 3;74(1):1-3. doi: 10.24875/RIC.21000206.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cyclophosphamide / adverse effects
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Transplantation, Autologous

Substances

  • Cyclophosphamide